Patent ID: 8628920
Filing Date: 2014-01-14
Classification: G01N

Abstract:
1. A method for determining risk of metastatic liver cancer, comprising the steps of: (A) providing a sample obtained from a subject; (B) assessing the RNA expression level of four subtypes of α-mannosidase genes consisting of MAN1A1, MAN1A2, MAN1B1 and MAN1C1 in the sample by detecting MAN1A1, MAN1A2, MAN1B1 and MAN1C1 RNA expression levels in the sample; (C) comparing the MAN1A1, MAN1A2, MAN1B1 and MAN1C1 expression levels in the sample with MAN1A1, MAN1A2, MAN1B1 and MAN1C1 expression levels in a normal control; and (D) determining whether the subject has a risk of metastasis of liver cancer in accordance with the result of step (C);